↓ Skip to main content

Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome

Overview of attention for article published in Diabetology & Metabolic Syndrome, November 2014
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome
Published in
Diabetology & Metabolic Syndrome, November 2014
DOI 10.1186/1758-5996-6-119
Pubmed ID
Authors

Parco M Siu, Queenie S Yuen

Abstract

Metabolic syndrome (MetS) refers to a cluster of cardiovascular risk factors including hyperglycemia, dyslipidemia, abdominal obesity and hypertension. An effective detection of MetS not only reflects the prediction risk of diabetes mellitus and cardiovascular diseases but also helps to plan for management strategy which could reduce the healthcare burden of the society. This study aimed to compare the use of hemoglobin A1c (HbA1c) to fasting plasma glucose (FPG) as the hyperglycemic component in MetS diagnosis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 2%
United States 1 2%
Unknown 43 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 20%
Student > Postgraduate 6 13%
Student > Doctoral Student 5 11%
Student > Ph. D. Student 5 11%
Student > Bachelor 4 9%
Other 9 20%
Unknown 7 16%
Readers by discipline Count As %
Medicine and Dentistry 15 33%
Biochemistry, Genetics and Molecular Biology 5 11%
Nursing and Health Professions 5 11%
Social Sciences 3 7%
Sports and Recreations 2 4%
Other 6 13%
Unknown 9 20%